Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.

The researchers found that after 64 weeks, participants had a mean weight loss of −16.7%, with a mean semaglutide dose of 1.08mg/week.

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight -- without causing nausea.

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

A San Antonio weight loss clinic owner is encouraging consumers of the GLP-1 drug semaglutide not to panic now that the FDA ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without ...

Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 ...

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

A federal deadline ending the sale of compounded semaglutide (Ozempic, Wegovy) is now in effect after a similar one for ...

Ozempic is approved for the management of type 2 diabetes, but it’s also used off-label to support weight loss. Its active ingredient, semaglutide, is a synthetic version of the natural hormone ...